Candriam SCA’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-85,661
Closed -$3.88M 678
2024
Q4
$3.88M Sell
85,661
-4,339
-5% -$197K 0.02% 394
2024
Q3
$5.29M Hold
90,000
0.03% 353
2024
Q2
$3.54M Hold
90,000
0.02% 394
2024
Q1
$5.98M Buy
+90,000
New +$5.98M 0.04% 314